Literature DB >> 18666317

Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Asmaa-Ibrahim Gomaa1, Shahid-A Khan, Mireille-B Toledano, Imam Waked, Simon-D Taylor-Robinson.   

Abstract

Hepatocellular carcinoma (HCC) is the commonest primary malignant cancer of the liver in the world. Given that the burden of chronic liver disease is expected to rise owing to increasing rates of alcoholism, hepatitis B and C prevalence and obesity-related fatty liver disease, it is expected that the incidence of HCC will also increase in the foreseeable future. This article summarizes the international epidemiology, the risk factors and the pathogenesis of HCC, including the roles of viral hepatitis, toxins, such as alcohol and aflatoxin, and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18666317      PMCID: PMC2731180          DOI: 10.3748/wjg.14.4300

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  129 in total

1.  Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients.

Authors:  L H Ou; G Y Chau; S H Tsay; J H Chiu; J C Wu; K L King; C C Loong; C W Wu; W Y Lui
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1997-07

2.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

3.  Epidemiology of human aflatoxin exposures and their relationship to liver cancer.

Authors:  J D Groopman; P Scholl; J S Wang
Journal:  Prog Clin Biol Res       Date:  1996

4.  HCV-associated hepatocellular carcinoma without cirrhosis.

Authors:  A el-Refaie; K Savage; S Bhattacharya; S Khakoo; T J Harrison; M el-Batanony; S Nasr; N Mokhtar; K Amer; P J Scheuer; A P Dhillon
Journal:  J Hepatol       Date:  1996-03       Impact factor: 25.083

Review 5.  The epidemiology of antibody to hepatitis C in Egypt.

Authors:  R G Hibbs; A L Corwin; N F Hassan; M Kamel; M Darwish; R Edelman; N T Constantine; M R Rao; A S Khalifa; S Mokhtar
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

6.  Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.

Authors:  J García-Samaniego; M Rodríguez; J Berenguer; R Rodríguez-Rosado; J Carbó; V Asensi; V Soriano
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

7.  Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma.

Authors:  H Kuper; A Tzonou; E Kaklamani; C C Hsieh; P Lagiou; H O Adami; D Trichopoulos; S O Stuver
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

8.  Excess risk of primary liver cancer in patients with diabetes mellitus.

Authors:  H O Adami; W H Chow; O Nyrén; C Berne; M S Linet; A Ekbom; A Wolk; J K McLaughlin; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1996-10-16       Impact factor: 13.506

9.  Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP).

Authors:  G Realdi; G Fattovich; S Hadziyannis; S W Schalm; P Almasio; J Sanchez-Tapias; E Christensen; G Giustina; F Noventa
Journal:  J Hepatol       Date:  1994-10       Impact factor: 25.083

10.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

View more
  229 in total

1.  Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.

Authors:  Xiaodong Wen; Lacy Reynolds; Rohit S Mulik; Soo Young Kim; Tim Van Treuren; Liem H Nguyen; Hao Zhu; Ian R Corbin
Journal:  Gastroenterology       Date:  2015-10-17       Impact factor: 22.682

Review 2.  Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.

Authors:  Yoshitaka Takuma; Kazuhiro Nouso
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 3.  microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma.

Authors:  Xiaofei Li; Wenjun Yang; Lianqing Lou; Yongxin Chen; Shuang Wu; Guoqiang Ding
Journal:  Dig Dis Sci       Date:  2014-01-04       Impact factor: 3.199

4.  Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.

Authors:  David J Hughes; Talita Duarte-Salles; Sandra Hybsier; Antonia Trichopoulou; Magdalena Stepien; Krasimira Aleksandrova; Kim Overvad; Anne Tjønneland; Anja Olsen; Aurélie Affret; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Verena Katzke; Rudolf Kaaks; Heiner Boeing; Christina Bamia; Pagona Lagiou; Eleni Peppa; Domenico Palli; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Hendrik Bastiaan Bueno-de-Mesquita; Petra H Peeters; Dagrun Engeset; Elisabete Weiderpass; Cristina Lasheras; Antonio Agudo; Maria-José Sánchez; Carmen Navarro; Eva Ardanaz; Miren Dorronsoro; Oskar Hemmingsson; Nicholas J Wareham; Kay-Tee Khaw; Kathryn E Bradbury; Amanda J Cross; Marc Gunter; Elio Riboli; Isabelle Romieu; Lutz Schomburg; Mazda Jenab
Journal:  Am J Clin Nutr       Date:  2016-06-29       Impact factor: 7.045

Review 5.  Pesticide exposure and liver cancer: a review.

Authors:  Trang VoPham; Kimberly A Bertrand; Jaime E Hart; Francine Laden; Maria M Brooks; Jian-Min Yuan; Evelyn O Talbott; Darren Ruddell; Chung-Chou H Chang; Joel L Weissfeld
Journal:  Cancer Causes Control       Date:  2017-02-13       Impact factor: 2.506

Review 6.  Infection, stem cells and cancer signals.

Authors:  S Sell
Journal:  Curr Pharm Biotechnol       Date:  2011-02-01       Impact factor: 2.837

Review 7.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 8.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

9.  Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.

Authors:  Manuela Cabiati; Melania Gaggini; Paolo De Simone; Silvia Del Ry
Journal:  Clin Exp Med       Date:  2020-11-17       Impact factor: 3.984

10.  Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Yonggang Wei; Limei Luo; Xi Chen; Lvnan Yan; Bo Li
Journal:  Tumour Biol       Date:  2012-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.